West Pharmaceutical exec exercises and sells shares
West Pharmaceutical Services senior vice president and chief HR officer Annette F. Favorite exercised stock options and sold shares of common stock.
Rhea-AI Filing Summary
West Pharmaceutical Services senior vice president and chief HR officer Annette F. Favorite exercised stock options and sold shares of common stock. On April 27, she exercised options to acquire 2,817 shares at $83.47 per share and then sold 2,817 shares in an open-market transaction at a weighted average price of $305.2018 per share.
After these transactions, she directly holds 16,828.4906 shares of common stock and indirectly holds 4,966.6170 shares through a Non-Qualified Deferred Compensation Plan, showing she retains a meaningful equity stake in the company despite the net sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and Sale: 2,817 shares ($625K approx. pre-tax spread)
Exercise and Sale
4 txns
Insider
Favorite Annette F
Role
Sr. VP & Chief HR Officer
Sold
2,817 shs ($860K)
Approx. gross sale proceeds
$860K
Approx. exercise cost
$235K
Approx. pre-tax spread
$625K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Options (Right to Buy) | 2,817 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,817 | $83.47 | $235K |
| Sale | Common Stock | 2,817 | $305.2018 | $860K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Options (Right to Buy) — 5,635 contracts (Direct);
Common Stock — 16,828.4906 shares (Direct);
Common Stock — 4,966.617 shares (Indirect, Non-Qualified Deferred Compensation Plan)
Footnotes (2)
- F1. The price reported in Column 4 is a weighted average price.
- F2. This award granted on February 21, 2017 vested in four equal annual installments beginning on February 21, 2018.
Key Figures
Shares sold: 2,817 shares
Sale price (weighted average): $305.2018 per share
Options exercised: 2,817 shares
+5 more
8 metrics
Shares sold
2,817 shares
Open-market sale of common stock on April 27
Sale price (weighted average)
$305.2018 per share
Price for 2,817 common shares sold
Options exercised
2,817 shares
Common stock acquired via option exercise
Option exercise price
$83.47 per share
Strike price for exercised stock options
Direct holdings after transactions
16,828.4906 shares
Common stock directly held post-transaction
Indirect holdings after transactions
4,966.6170 shares
Common stock held via Non-Qualified Deferred Compensation Plan
Remaining options
5,635.0000 options
Stock Options (Right to Buy) position after exercise
Option expiration date
February 21, 2027
Expiration of exercised option grant originally dated 2017-02-21
Key Terms
Non-Qualified Deferred Compensation Plan, Stock Options (Right to Buy), weighted average price, Exercise or conversion of derivative security
4 terms
Non-Qualified Deferred Compensation Plan financial
"nature_of_ownership: "Non-Qualified Deferred Compensation Plan""
An arrangement where an employer agrees to pay part of an employee’s salary or bonus at a later date, often to attract or keep key staff. Think of it as a company IOU or a delayed paycheck held on the company’s books rather than in a protected retirement account; investors care because these promises create future cash obligations that are typically unsecured and depend on the company’s financial health, affecting risk, liabilities, and cash-flow planning.
Stock Options (Right to Buy) financial
"security_title: "Stock Options (Right to Buy)""
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Exercise or conversion of derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security""
FAQ
What insider transactions did West Pharmaceutical (WST) report for Annette F. Favorite?
Annette F. Favorite exercised options for 2,817 West Pharmaceutical common shares at $83.47 and sold 2,817 shares at a weighted average price of $305.2018. These transactions occurred on April 27 and were reported on a Form 4 insider filing.
What stock options did the West Pharmaceutical (WST) executive exercise?
She exercised stock options covering 2,817 shares of West Pharmaceutical common stock at an exercise price of $83.47 per share. The options were originally granted on February 21, 2017 and vested in four equal annual installments beginning February 21, 2018.
Was the reported West Pharmaceutical (WST) sale a routine open-market transaction?
The Form 4 identifies the 2,817-share disposition with transaction code S, described as a sale in the open market or private transaction. Footnotes state the reported price is a weighted average, indicating execution across multiple trades aggregated at a single average price.
AI-generated analysis. How Rhea-AI works. Not financial advice.
